Correlation analyses between MIBG myocardial scintigraphy and monoamine levels in dementia with Lewy bodies show potential link with the serotonergic system
- PMID: 40487744
- PMCID: PMC12143658
- DOI: 10.1016/j.prdoa.2025.100346
Correlation analyses between MIBG myocardial scintigraphy and monoamine levels in dementia with Lewy bodies show potential link with the serotonergic system
Abstract
Setting: Dementia with Lewy bodies (DLB) remains poorly understood and frequently misdiagnosed, complicated by co-pathology with other dementia forms. DLB patients often present with autonomic dysfunction and peripheral Lewy body pathology alongside central lesions. Monoaminergic neurotransmitter systems seem an early target for DLB pathology, especially the noradrenergic system. Noradrenaline analogue 123I-metaiodobenzylguanidine (MIBG) is considered an indicative biomarker for peripheral noradrenergic sympathetic denervation.
Objectives: Our aim was to measure paired monoaminergic levels and MIBG scintigraphy values in DLB patients, exploring a possible link between noradrenergic neurotransmission and peripheral denervation.
Design: 44 patients with a possible DLB diagnosis entered the study. Peripheral uptake of 123I-MIBG was determined by the heart-to-mediastinum (H/M) ratio, as a measure for noradrenergic sympathetic denervation. In cerebrospinal fluid (CSF), serum and plasma samples, monoamines ((nor)adrenaline ((N)A), 5-hydroxytryptamin (5-HT, serotonin), dopamine (DA)) and respective metabolites (3-methoxy-4-hydroxyphenylglycol (MHPG), 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA) and 3,4-dihydroxyphenylacetic acid (DOPAC)), were measured by means of reversed-phase ultrahigh-performance liquid chromatography with electrochemical detection.
Results: We found significant correlations between the H/M ratio and serum 5-HIAA, plasma 5-HT, plasma 5-HIAA/5-HT and plasma HVA/5-HIAA, but no further correlations with the noradrenergic system. CSF-serum MHPG, CSF-serum DOPAC, CSF-serum HVA, CSF-plasma MHPG, CSF plasma NA, CSF-plasma DOPAC, CSF-plasma MHPG/NA and CSF-plasma DOPAC/DA were significantly correlated.
Conclusions: These results show an association between the H/M ratio and serotonergic system, but not between peripheral noradrenergic denervation and circulating noradrenergic levels.
Keywords: 5-HIAA; 5-HT; Biogenic amines; DLB; Dopamine; H/M ratio; Noradrenaline; Norepinephrine; Serotonin; UPLC.
© 2025 The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures

Similar articles
-
Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease.J Parkinsons Dis. 2018;8(1):71-84. doi: 10.3233/JPD-171228. J Parkinsons Dis. 2018. PMID: 29480224
-
The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer's disease.Alzheimers Res Ther. 2015 Feb 11;7(1):7. doi: 10.1186/s13195-014-0090-1. eCollection 2015. Alzheimers Res Ther. 2015. PMID: 25717350 Free PMC article.
-
Sampling issues of cerebrospinal fluid and plasma monoamines: Investigation of the circadian rhythm and rostrocaudal concentration gradient.Neurochem Int. 2019 Sep;128:154-162. doi: 10.1016/j.neuint.2019.04.015. Epub 2019 Apr 26. Neurochem Int. 2019. PMID: 31034914
-
[Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].Rinsho Shinkeigaku. 2008 Jan;48(1):11-24. doi: 10.5692/clinicalneurol.48.11. Rinsho Shinkeigaku. 2008. PMID: 18386627 Review. Japanese.
-
Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?Med Biol. 1985;63(1):1-17. Med Biol. 1985. PMID: 2582215 Review.
References
-
- World Health Organization (2017, December 7). Global action plan on the public health response to dementia 2017 – 2025. https://www.who.int/publications/i/item/global-action-plan-on-the-public....
-
- McKeith I.G., Ferman T.J., Thomas A.J., Blanc F., Boeve B.F., Fujishiro H., Kantarci K., Muscio C., O'Brien J.T., Postuma R.B., Aarsland D., Ballard C., Bonanni L., Donaghy P., Emre M., Galvin J.E., Galasko D., Goldman J.G., Gomperts S.N., Honig L.S., prodromal DLB Diagnostic Study Group Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. 2020;94(17):743–755. doi: 10.1212/WNL.0000000000009323. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Medical